Discontinued — last reported Q4 '25
American Tower Acquisitions decreased by 43.5% to $19.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 87.0%, from $147.60M to $19.20M. Over 4 years (FY 2021 to FY 2025), Acquisitions shows a downward trend with a -60.8% CAGR.
High spending indicates an aggressive growth strategy, while low spending may indicate a focus on organic growth or debt reduction.
This represents the net cash outflow for the purchase of other businesses or strategic assets, adjusted for any cash acq...
Highly variable; pharmaceutical companies frequently use M&A to offset patent cliffs and expand therapeutic portfolios.
cf_acquisitions| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $8.77B | $712.70M | $9.71B | $128.60M | $89.70M | $140.80M | $189.90M | $60.90M | $30.30M | $60.70M | $16.10M | $44.70M | $10.30M | $59.90M | $8.10M | $147.60M | $184.70M | $87.90M | $34.00M | $19.20M |
| QoQ Change | — | -91.9% | >999% | -98.7% | -30.2% | +57.0% | +34.9% | -67.9% | -50.2% | +100.3% | -73.5% | +177.6% | -77.0% | +481.6% | -86.5% | >999% | +25.1% | -52.4% | -61.3% | -43.5% |
| YoY Change | — | — | — | — | -99.0% | -80.2% | -98.0% | -52.6% | -66.2% | -56.9% | -91.5% | -26.6% | -66.0% | -1.3% | -49.7% | +230.2% | >999% | +46.7% | +319.8% | -87.0% |